Summary
Updated Aug 31, 2026
Joseph P. Lyssikatos is CHIEF SCIENTIFIC OFFICER of Enliven Therapeutics, Inc. (ELVN). 15 SEC Form 4 filings on record going back to 2024, most recently on 18 February 2026. Most recent open-market trade: sold $145K of ELVN on 10 February 2026. Lifetime open-market sales: $7.24M.
Recent Transactions
20Every recent SEC Form 4 transaction Joseph P. Lyssikatos has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Joseph P. Lyssikatos go back to 2024: 15 primary Form 4 filings, an average of 5.0 per year. 18 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Joseph P. Lyssikatos files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ORBIMED ADVISORS LLC - $51.68M of ELVN open-market activity in the last 12 months
- Mika K. Derynck - $9.56M of ELVN open-market activity in the last 12 months
- Helen Louise Collins - $5.14M of ELVN open-market activity in the last 12 months
- Anish Patel - $1.74M of ELVN open-market activity in the last 12 months
- Benjamin Hohl - $1.30M of ELVN open-market activity in the last 12 months
- Lori Anne Kunkel - $850K of ELVN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Joseph P. Lyssikatos?
Joseph P. Lyssikatos is a corporate insider, tracked as CHIEF SCIENTIFIC OFFICER of Enliven Therapeutics, Inc. (ELVN). InsiderAlpha holds 15 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Joseph P. Lyssikatos last file a Form 4?
The most recent primary Form 4 on record is dated 18 February 2026, one of 15 filings going back to 2024.
Has Joseph P. Lyssikatos been buying or selling stock?
Recorded transactions: 0 open-market purchases and 26 open-market sales ($7.24M) across all tracked filings.
Where can I see all of Joseph P. Lyssikatos's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Joseph P. Lyssikatos and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial